Back to Rankings

CING

CingulateD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CING vs peer average
48/100
CING vs. peer average (D vs. D)
Grade spread
B 2 · C 2 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

LTRN is the first available peer comparator.

Small-cap oncology/therapeutics developer with similar market cap and typical program-stage volatility—useful as an event-driven biotech comparator.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerLTRNLantern
CING
Cingulate
LTRN
Lantern
Grade
D
F
Momentum
5
27
Value
41
41
Sentiment
100
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs LTRN

CING / LTRN
Grade Position
In line
CING vs. peer average (D vs. D)
48/100
Momentum
5
LTRN
Value
41
CING
Sentiment
100
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CING
1
LTRN
LTRN
F
20/100
+1
2
RNTX
RNTX
F
20/100
+1
3
DMRA
DMRA
B
80/100
-2
4
ESLA
Estrella Immunopharma Inc Common
F
20/100
+1
5
MREO
Mereo BioPharma Group plc ADR
C
60/100
-1
LTRN is the first peer returned for this comparison set.